Peter Milder
Family Medicine · Alexandria, LANPI 1952304776
Payments from drug & device makers
Across 223 payments — averaging $11.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$318
- AstraZeneca$277
- AbbVie$276
- GSK$260
- Novo Nordisk$179
- Boehringer Ingelheim$175
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,59798%
- Education$442%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 45 | $318 |
| AstraZeneca | 10 | $277 |
| AbbVie | 28 | $276 |
| GSK | 18 | $260 |
| Novo Nordisk | 17 | $179 |
| Boehringer Ingelheim | 15 | $175 |
| Sanofi-aventis U.S. LLC | 10 | $147 |
| Johnson & Johnson | 15 | $138 |
| Merck | 13 | $131 |
| Lilly USA, LLC | 12 | $129 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $126 |
| Abbott | 1 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $100 |
| Amarin Pharma, Inc. | 5 | $91 |
| Shire North American Group Inc | 3 | $61 |
| Novartis | 3 | $37 |
| Amgen | 2 | $29 |
| Mylan Specialty L.p. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Confirm Rx$101
How this compares
$2,640 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 66 | $57,081 |
| TrulicityDulaglutide | 24 | $26,616 |
| VraylarCariprazine Hcl | 17 | $24,892 |
| EliquisApixaban | 19 | $24,562 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $23,774 |
| XareltoRivaroxaban | 18 | $21,334 |
| OzempicSemaglutide | 16 | $17,474 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $10,918 |
| Gabapentin | 186 | $3,159 |
| Atorvastatin Calcium | 313 | $2,992 |
| Pantoprazole Sodium | 241 | $2,903 |
| Bisoprolol Fumarate | 122 | $2,848 |
| Ezetimibe | 122 | $2,757 |
| Levothyroxine Sodium | 213 | $1,904 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $1,815 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $175 | $57,08166 claims |
| Lilly USA, LLCTrulicity | $129 | $26,61624 claims |
| AbbVieVraylar, Synthroid | $276 | $26,57342 claims |
| PfizerEliquis | $318 | $24,56219 claims |
| GSKTrelegy Ellipta | $260 | $23,77426 claims |
| Johnson & JohnsonXarelto | $138 | $21,33418 claims |
| Novo NordiskOzempic | $179 | $17,47416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Alexandria
- Michael ScrepetisAlexandria$27K
- Gregory BevelsAlexandria$24K
- Kenneth BrownAlexandria$17K
- Gregory BrianAlexandria$15K
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Stephen JonesNew Orleans$513K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.